The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
- PMID: 36989901
- DOI: 10.1016/j.intimp.2023.110081
The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
Erratum in
-
Corrigendum to "The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics" [Int. Immunopharmacol. 118 (2023) 110081].Int Immunopharmacol. 2023 Dec;125(Pt A):111089. doi: 10.1016/j.intimp.2023.111089. Epub 2023 Oct 21. Int Immunopharmacol. 2023. PMID: 37872057 No abstract available.
Abstract
The complement system is one of the oldest known tightly regulated host defense systems evolved for efficiently functioning cell-based immune systems and antibodies. Essentially, the complement system acts as a pivot between the innate and adaptive arms of the immune system. The complement system collectively represents a cocktail of ∼50 cell-bound/soluble glycoproteins directly involved in controlling infection and inflammation. Activation of the complement cascade generates complement fragments like C3a, C4a, and C5a as anaphylatoxins. C5a is the most potent proinflammatory anaphylatoxin, which is involved in inflammatory signaling in a myriad of tissues. This review provides a comprehensive overview of human C5a in the context of its structure and signaling under several pathophysiological conditions, including the current and future therapeutic applications targeting C5a.
Keywords: C5a; C5aR1, C5aR2; Disease; Therapeutics.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.FASEB J. 2020 Jun;34(6):7540-7560. doi: 10.1096/fj.201902397R. Epub 2020 Apr 17. FASEB J. 2020. PMID: 32301538 Free PMC article.
-
The Complement C3a and C5a Signaling in Renal Diseases: A Bridge between Acute and Chronic Inflammation.Nephron. 2024;148(10):712-723. doi: 10.1159/000538241. Epub 2024 Mar 8. Nephron. 2024. PMID: 38452744 Review.
-
Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.Curr Protoc Immunol. 2020 Sep;130(1):e100. doi: 10.1002/cpim.100. Curr Protoc Immunol. 2020. PMID: 32710701
-
New concepts on the therapeutic control of complement anaphylatoxin receptors.Mol Immunol. 2017 Sep;89:36-43. doi: 10.1016/j.molimm.2017.05.015. Epub 2017 May 30. Mol Immunol. 2017. PMID: 28576324 Review.
-
Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.J Cell Biochem. 2023 Feb;124(2):266-281. doi: 10.1002/jcb.30360. Epub 2022 Dec 24. J Cell Biochem. 2023. PMID: 36565188
Cited by
-
Dysregulated complement activation during acute myocardial infarction leads to endothelial glycocalyx degradation and endothelial dysfunction via the C5a:C5a-Receptor1 axis.Front Immunol. 2024 Jul 11;15:1426526. doi: 10.3389/fimmu.2024.1426526. eCollection 2024. Front Immunol. 2024. PMID: 39055717 Free PMC article.
-
Brain-penetrant complement inhibition mitigates neurodegeneration in an Alzheimer's disease mouse model.Brain. 2025 Mar 6;148(3):941-954. doi: 10.1093/brain/awae278. Brain. 2025. PMID: 39215579 Free PMC article.
-
C3 Glomerulopathy: Novel Treatment Paradigms.Kidney Int Rep. 2023 Dec 16;9(3):569-579. doi: 10.1016/j.ekir.2023.12.007. eCollection 2024 Mar. Kidney Int Rep. 2023. PMID: 38481517 Free PMC article. Review.
-
C5aR2 Deficiency Lessens C5aR1 Distribution and Expression in Neutrophils and Macrophages.J Immunol Res. 2024 Jul 10;2024:2899154. doi: 10.1155/2024/2899154. eCollection 2024. J Immunol Res. 2024. PMID: 39021433 Free PMC article.
-
Prenatal Inflammation Reprograms Hypothalamic-Pituitary-Gonadal Axis Development in Female Rats.Inflammation. 2025 Feb 5. doi: 10.1007/s10753-025-02243-2. Online ahead of print. Inflammation. 2025. PMID: 39909991
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous